Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Extracranial Stereotactic Body Radiation Therapy (SBRT) Added to Standard Treatment Versus Standard Treatment Alone in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases

NCT03143322 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT03143322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03143322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Extracranial Stereotactic Body Radiation Therapy (SBRT) Added to Standard Treatment Versus Standard Treatment Alone in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases
Lead sponsor
UNICANCER
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 24, 2018
Completion date
July 31, 2027
Enrollment
168 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, metastatic breast cancer, metastatic lung cancer, metastatic prostate cancer